SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-24-008538
Filing Date
2024-12-20
Accepted
2024-12-20 16:31:45
Documents
1
Period of Report
2024-12-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7612
  Complete submission text file 0001562180-24-008538.txt   9004
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
MAHON PAUL A (Reporting) CIK: 0001231589 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 241568421